-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Mac-2-binding Protein Glycosylation isomer well correlates with the Controlling Nutritional Status Score in Hepatitis Viruses-related Liver Diseases
Hiroki Nishikawa*, Ryo Takata, Kazunori Yoh, Hirayuki Enomoto, Noriko Ishii, Yoshinori Iwata, Takashi Nishimura, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Kunihiro Hasegawa, Yukihisa Yuri, Tomoyuki Takashima, Hiroko Iijima, Shuhei Nishiguchi
Research Article: Clinical Investigation
-
Mac-2-binding Protein Glycosylation isomer well correlates with the Controlling Nutritional Status Score in Hepatitis Viruses-related Liver Diseases
Hiroki Nishikawa*, Ryo Takata, Kazunori Yoh, Hirayuki Enomoto, Noriko Ishii, Yoshinori Iwata, Takashi Nishimura, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Kunihiro Hasegawa, Yukihisa Yuri, Tomoyuki Takashima, Hiroko Iijima, Shuhei Nishiguchi
Research Article: Clinical Investigation
-
Mac-2-binding Protein Glycosylation isomer well correlates with the Controlling Nutritional Status Score in Hepatitis Viruses-related Liver Diseases
Hiroki Nishikawa*, Ryo Takata, Kazunori Yoh, Hirayuki Enomoto, Noriko Ishii, Yoshinori Iwata, Takashi Nishimura, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Kunihiro Hasegawa, Yukihisa Yuri, Tomoyuki Takashima, Hiroko Iijima, Shuhei Nishiguchi
Research Article: Clinical Investigation
-
Mac-2-binding Protein Glycosylation isomer well correlates with the Controlling Nutritional Status Score in Hepatitis Viruses-related Liver Diseases
Hiroki Nishikawa*, Ryo Takata, Kazunori Yoh, Hirayuki Enomoto, Noriko Ishii, Yoshinori Iwata, Takashi Nishimura, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Kunihiro Hasegawa, Yukihisa Yuri, Tomoyuki Takashima, Hiroko Iijima, Shuhei Nishiguchi
Research Article: Clinical Investigation
-
Mac-2-binding Protein Glycosylation isomer well correlates with the Controlling Nutritional Status Score in Hepatitis Viruses-related Liver Diseases
Hiroki Nishikawa*, Ryo Takata, Kazunori Yoh, Hirayuki Enomoto, Noriko Ishii, Yoshinori Iwata, Takashi Nishimura, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Kunihiro Hasegawa, Yukihisa Yuri, Tomoyuki Takashima, Hiroko Iijima, Shuhei Nishiguchi
Research Article: Clinical Investigation
-
Mac-2-binding Protein Glycosylation isomer well correlates with the Controlling Nutritional Status Score in Hepatitis Viruses-related Liver Diseases
Hiroki Nishikawa*, Ryo Takata, Kazunori Yoh, Hirayuki Enomoto, Noriko Ishii, Yoshinori Iwata, Takashi Nishimura, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Kunihiro Hasegawa, Yukihisa Yuri, Tomoyuki Takashima, Hiroko Iijima, Shuhei Nishiguchi
Research Article: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
Neuroprotective agents in ischemic stroke: past failures and future opportunities
Jiangyong Min, Muhammad U Farooq, Philip B Gorelick
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neuroprotective agents in ischemic stroke: past failures and future opportunities
Jiangyong Min, Muhammad U Farooq, Philip B Gorelick
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neuroprotective agents in ischemic stroke: past failures and future opportunities
Jiangyong Min, Muhammad U Farooq, Philip B Gorelick
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neuroprotective agents in ischemic stroke: past failures and future opportunities
Jiangyong Min, Muhammad U Farooq, Philip B Gorelick
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neuroprotective agents in ischemic stroke: past failures and future opportunities
Jiangyong Min, Muhammad U Farooq, Philip B Gorelick
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neuroprotective agents in ischemic stroke: past failures and future opportunities
Jiangyong Min, Muhammad U Farooq, Philip B Gorelick
Review: Clinical Trail Outcomes: Clinical Investigation
-
The importance of monitoring adverse events in statin, and other, clinical trials
Beatrice Alexandra Golomb
Editorial: Clinical Investigation
-
The importance of monitoring adverse events in statin, and other, clinical trials
Beatrice Alexandra Golomb
Editorial: Clinical Investigation
-
The importance of monitoring adverse events in statin, and other, clinical trials
Beatrice Alexandra Golomb
Editorial: Clinical Investigation
-
The importance of monitoring adverse events in statin, and other, clinical trials
Beatrice Alexandra Golomb
Editorial: Clinical Investigation
-
The importance of monitoring adverse events in statin, and other, clinical trials
Beatrice Alexandra Golomb
Editorial: Clinical Investigation
-
The importance of monitoring adverse events in statin, and other, clinical trials
Beatrice Alexandra Golomb
Editorial: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
If Big Pharma pay, it can keep the doctor away
News and Views: Clinical Investigation
-
If Big Pharma pay, it can keep the doctor away
News and Views: Clinical Investigation
-
If Big Pharma pay, it can keep the doctor away
News and Views: Clinical Investigation
-
If Big Pharma pay, it can keep the doctor away
News and Views: Clinical Investigation
-
If Big Pharma pay, it can keep the doctor away
News and Views: Clinical Investigation
-
If Big Pharma pay, it can keep the doctor away
News and Views: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Treatment of malignant pleural mesothelioma: current status and future directions
Paolo Andrea Zucali, Rita De Sanctis, Fabio De Vincenzo, Matteo Simonelli, Elena Lorenzi, Matteo Perrino, Armando Santoro
Review Article: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation